Cash Flow - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.23 | -0.19 | -0.10 | -0.15 | -0.13 | 0.09 | 0.02 | -0.02 |
| Cash flow from investing | -0.52 | -0.40 | 0.14 | 0.02 | -0.10 | -0.42 | -0.02 | 0.00 |
| Cash flow from financing | 0.99 | 0.61 | 0.00 | 0.15 | 0.25 | 0.29 | 0.03 | 0.05 |
| Change in cash | 0.24 | 0.01 | 0.04 | 0.02 | 0.02 | -0.05 | 0.04 | 0.03 |
Show Quarterly Cash Flow
Cash Flow - Kymera Therapeutics, Inc. (KYMR)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.09 | -0.07 | -0.03 | -0.06 | -0.08 | -0.06 | -0.05 | -0.04 | -0.04 | 0.01 | -0.03 | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.02 | -0.02 | 0.13 | -0.01 | -0.01 | -0.01 | -0.01 |
| Cash flow from investing | -0.14 | -0.39 | -0.24 | 0.06 | 0.05 | 0.07 | -0.16 | 0.02 | -0.33 | 0.02 | 0.06 | 0.04 | 0.02 | -0.05 | -0.04 | 0.08 | 0.03 | -0.07 | -0.14 | 0.06 | 0.04 | 0.00 | -0.33 | -0.05 | -0.04 | 0.06 | -0.08 |
| Cash flow from financing | 0.02 | 0.71 | 0.04 | 0.25 | 0.00 | 0.00 | 0.25 | 0.00 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.20 | 0.00 | 0.09 | 0.02 | 0.00 |
| Change in cash | -0.21 | 0.24 | -0.22 | 0.25 | -0.03 | 0.01 | 0.04 | -0.03 | -0.02 | 0.03 | 0.03 | 0.00 | -0.02 | -0.09 | 0.08 | 0.04 | -0.01 | -0.10 | 0.07 | 0.03 | 0.02 | -0.02 | -0.01 | -0.06 | 0.04 | 0.07 | -0.09 |